Related content

Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy

By Merrick G.S.   Butler W.M.   Wallner K.E.   Lief J.H.   Hinerman-Mulroy A.   Galbreath R.W.  

Brachytherapy, Vol. 2, Iss. 3, 2003-09 ,pp. : 181-188

Elsevier

Access to resources Recommend Favorite

Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score

By Mueller-Lisse Ullrich   Swanson Mark   Vigneron Daniel   Kurhanewicz John  

European Radiology, Vol. 17, Iss. 2, 2007-02 ,pp. : 371-378

Springer Publishing Company

Access to resources Recommend Favorite

A survival score for patients with metastatic spinal cord compression from prostate cancer

By Rades D.   Douglas S.   Veninga T.   Bajrovic A.   Stalpers L.J.A.   Hoskin P.J.   Rudat V.   Schild S.E.  

Strahlentherapie und Onkologie, Vol. 188, Iss. 9, 2012-09 ,pp. : 802-806

Springer Publishing Company

Access to resources Recommend Favorite

Specificity and accuracy of TRUS-measured PSA-density and transition zone-PSA in the diagnosis of prostate cancer

By Michielsen D.P.J.   De Boe V.R.   Braeckman J.G.   Keuppens F.I.  

European Journal of Ultrasound, Vol. 8, Iss. 2, 1998-11 ,pp. : 125-128

Elsevier

Access to resources Recommend Favorite

A validated survival score for breast cancer patients with metastatic spinal cord compression

By Rades D.   Douglas S.   Schild S.E.  

Strahlentherapie und Onkologie, Vol. 189, Iss. 1, 2013-01 ,pp. : 41-46

Springer Publishing Company

Access to resources Recommend Favorite